C-Ha-ras-1 restriction fragment length polymorphism in the patients with multiple primary cancers and non-small cell lung cancer

Genetika

Volumn 33, Issue 1, 1997, Pages 96-100

  Gaspar'yan, A V ^a   Sel'chuk, V Yu ^a   Yakubovskaya, M G ^a   Zborovskaya, I B ^a   Tatosyan, A G ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ALLELE; ARTICLE; CELL DIFFERENTIATION; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MULTIPLE CANCER; ONCOGENE RAS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; GENE FREQUENCY; GENES, RAS; GENOTYPE; HUMANS; LUNG NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0030629121     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Capon D.J., Chen E.Y., Levinson A.D. et al. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue // Nature. 1983. V. 302. P. 33-37.
2. Krontiris T.G., Di Martina N.A., Colb M., Parkinson D.R. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients//Nature. 1985. V. 313. P. 369-374.
3. Vineis P., Caporaso N. The analysis of restriction fragment length polymorphism in human cancer: a review from an epidemiological perspective // Int. J. Cancer. 1991. V. 47. P. 26-30.
4. Krontiris T.G., Devline B., Karp D.D. et al. An association between the risk of cancer and mutations in the HRASI minisatellite locus // N. Engl. J. Med. 1993. V. 329. P. 517-523.
5. Wyllie F.S., Wynford-Thomas V., Lemoine N.R. et al. Haras restriction fragment length polymorphisms in colorectal cancer // Br. J. Cancer. 1988. V. 57. P. 135-138.
6. Heighway J., Thatcher N., Cerny T. et al. Genetic predisposition to lung cancer // Br. J. Cancer. 1986. V. 53. P. 453-457.
7. Ryberg D., Tefre T., Ovrebo S. et al. Ha-ras-l alleles in Norwegian lung cancer patients // Hum. Genet. 1990. V. 86. P. 40-44.
8. Srivastava S., Zou Z., Pirollo K. et al. Germline transmission of a mutatedp53 gene in a cancer prone family with LiFraumeny syndrom // Nature. 1990. V. 348. P. 747-749.
9. Devlin B., Krontiris T., Risch N. Population genetics of the HRASI Minisatellite Locus // Am. J. Hum. Genet. 1993. V. 53. P. 1298-1305.
10. Green M., Krontiris T.G. Allelic variation of reporter gene activation by the HRASI minisatellite // Genomics. 1993. V. 17. P. 429-434.
11. Barbadd M. Ras oncogenes: their role in neoplasia // Europ. J. Clin. Investigation. 1990. V. 20. P. 225-235.
12. Corominas M., Kamino H., Leon J., Pellicer A. Oncogene activation in human benign tumors of the skin (keratoacanthomas): Is HRAS involved in differentiations as well as proliferation? // Proc. Natl. Acad. Sci. USA. 1989. V. 86. P. 6372-6376.